- Tags: dry eye
Research
I-C eye drops ease mild-to-moderate dry eye in early trial
Small open-label trial found that iota-carrageenan eye drops cut dry eye symptoms by more than half under adverse conditions, with strong tolerability and no safety flags.Research
New data supports omega-3s for glaucoma in DED patients
Patients had roughly half the 5-year risk of developing glaucoma, though investigators stop short of claiming cause and effect.Pipeline
Aldeyra to formally appeal third reproxalap CRL
Company to submit a formal dispute resolution request following Type A and D meetings with FDA over the investigational DED drop.Products
Eyetamins by Optase target eyes prone to dryness with omega-7
Plant-based, softgel supplements are formulated to address long-term eye health with moisture balance support; upcoming AAO symposium dives deeper into the benefits.Research
Tear biomarker test tied to accurate dry eye severity classification
Tear lymphotoxin-α (LTA) not only distinguishes dry eye severity but also identifies patients with significant symptoms—despite having little or no detectable ocular surface damage.Research
NEI-funded study explores indoor air quality for dry eye
Researchers from the Miller School of Medicine are evaluating the potential for low-cost indoor air quality improvements to help reduce dry eye symptoms.Research
PRK linked to more postop dry eye, visual disturbances than LASIK
Registry data shows that complication risk shifts by procedure and recovery window, with PRK carrying higher early rates of dry eye and visual disturbances.Products
Optometrist launches Ev’r Beauty, an eye-focused cosmetics brand
Dry eye specialist debuts new line of products clinically tested for ocular safety on sensitive eyes and dry eye patients.Pipeline
Bausch + Lomb dry eye combo drop advances to phase 3 evaluation
Formulation includes active ingredients of XIIDRA and MIEBO; positive data also reported on a first-in-class drop for targeting ocular pain signaling.Research
Does vitamin supplementation help DED?
Evidence suggests certain vitamins may show promise, but researchers say the data is not strong enough yet to support routine supplementation.Research
FGFR inhibitor cancer drugs linked to dry eye, corneal damage
Real-world analysis of the FDA's adverse event database flags ocular safety signals that extend past what clinical trials and drug labels report.Products
Harrow adds TYRVAYA's global rights to dry eye portfolio
Pending acquisition of Viatris's FDA-approved, varenicline nasal spray is worth up to $100 million and is expected to close by the end of 2026.Products
iBlink app targets dry eye relief with real-time blink monitoring
Eye health app seeks to address digital eye strain symptoms via webcam-based tracking and gentle on-screen reminders.Products
Saptalis launches cyclosporine 0.05% generic amid portfolio expansion
Generic of Allergan’s Restasis is indicated to increase tear production, targeting inflammation as an underlying cause of dry eye.Products
OCuSOFT launches Retaine Ultra PF in a multi-dose bottle
Marketed as a daily, multi-dose lubricant eye drop, this new addition offers fact-acting hydration and a “moisture-rich” formulation for sensitive eyes.Products
Bausch + Lomb launches Blink Triple Care PF eye drops
Preservative-free lubricant features hyaluronic acid and castor oil to offer a 3-in-1 extended dry eye symptom relief for up to 10 hours.Products
Upsher-Smith launches Restasis generic to US market
Latest generic version of Allergan’s Restasis will be available as single-use vials in two packaging options.Products
Rain Eyecare launches dedicated dry eye telehealth platform
Direct-to-consumer service offers personalized, prescription-based treatment plans from licensed providers—including a generic Restasis option.Events
B+L Vision Care Summit spotlights contact lens and technology advancements
Clinicians share insights on dry eye care, contact lens adoption, and patient-centered treatment approaches.Research